Vertex Pharma (VRTX) Tops Q2 EPS by 1c, Beats on Revenue; Offers FY26 Revenue Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/2/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
| Vertex Pharmaceuticals Inc (NASDAQ: VRTX) | Delayed: 558.88 +18.88 (3.50%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $540.00 | 52 Week High | $134.71 | |||
| Open | $550.73 | 52 Week Low | $73.31 | |||
| Day High | $563.80 | P/E | N/A | |||
| Day Low | $549.89 | EPS | $-1.98 | |||
| Volume | 3,036,944 | |||||
